Skip to main content
CompareTreatmentsCA

Weight Loss · Head to head

MyRocky vs Direct Meds: Generic or Brand-Name GLP-1?

Direct Meds advertises the lower entry price — from $99 a month — but sells brand-name GLP-1 injections and oral options. MyRocky starts at $149 a month for generic semaglutide dispensed by its own pharmacy. The headline prices point one way and the all-in twelve-month cost frequently points the other, which is exactly why entry pricing is the wrong number to compare these two on.

Updated · Editorial team · This page contains affiliate links; our verdict is not for sale.

The verdict

Winner: MyRocky

MyRocky. The integrated model is the deciding factor: an in-house telehealth clinic feeding an in-house pharmacy removes the third-party transfer step where most Canadian refill delays originate, and generic semaglutide holds its price as your dose escalates in a way brand-name products do not. MyRocky also names its clinical leadership publicly and backs the program with a six-month money-back guarantee. Direct Meds is the better fit for one specific reader — someone who wants a brand-name GLP-1 or an oral option at the lowest advertised entry point and is content to manage dispensing through a partner pharmacy. Get the twelve-month quote at your target dose from both before deciding.

Side by side

MyRocky compared with Direct Meds across 8 criteria
CriterionMyRockyDirect Meds
Medication offeredGeneric semaglutideBrand-name GLP-1 injections and oral options
Advertised entry priceFrom $149/monthFrom $99/month
Pharmacy modelIn-house pharmacyPartner pharmacy dispensing
Named clinical leadershipPublished — physician and pharmacist-in-charge namedLicensed Canadian physicians, not individually named
Quebec coverageYesAvailable nationwide
Shipping speedFree delivery includedFree shipping, 1–2 business days
Money-back guarantee6-month money-back guaranteeNot advertised
Consultation$99 one-timeTelehealth visit included

A ✓ marks the stronger option on that row only. Rows where neither is meaningfully ahead are left unmarked rather than forced into a winner.

Where each one is strong, and where it is not

MyRocky

Strengths

  • Generic semaglutide from $149/month, which holds as your dose escalates
  • In-house clinic and pharmacy — no third-party transfer step on refills
  • Clinical leadership named publicly, which is not universal in this market
  • 6-month money-back guarantee and unlimited support

Trade-offs

  • $99 one-time consultation before anything can be prescribed
  • No brand-name Ozempic, Wegovy or Mounjaro

Best for: Canadians who want the lowest sustained cost per month on semaglutide with the fewest fulfilment handoffs

Direct Meds

Strengths

  • Lowest advertised entry price of the Canadian programs we track, from $99/month
  • Brand-name GLP-1 injections plus oral options for people who cannot or will not inject
  • Telehealth visit and prescription included, no insurance required
  • Free shipping quoted at 1–2 business days

Trade-offs

  • Brand-name only — no generic semaglutide, so cost climbs faster with dose
  • Dispensing runs through partner pharmacies rather than in-house

Best for: Canadians who want a brand-name GLP-1 or an oral option at the lowest advertised starting price

Questions people ask about this matchup

Which is actually cheaper over a year?
It depends on the dose you settle at, which is why the entry price misleads. Brand-name GLP-1 pricing generally rises with dose, while generic semaglutide programs hold closer to a flat monthly figure. Ask both for a twelve-month quote at your expected maintenance dose, add any consultation fee, and compare those two numbers — not the advertised starting prices.
Does an in-house pharmacy actually matter?
It matters most at refill time. When the prescribing clinic and the dispensing pharmacy are the same organisation, there is no prescription transfer between two systems — which is where a large share of Canadian telehealth refill delays come from. It is not a clinical quality difference, it is a reliability one.
Are oral GLP-1 options as effective as injections?
Oral semaglutide is authorised in Canada, but the doses and the evidence base are not identical to the injectable products, and clinical trials of injectable GLP-1s have generally shown larger average weight reduction. This is a decision for the clinician assessing you, taking your history and your tolerance for injections into account.

Keep comparing

References and further reading

  1. Health Canada, Canada approves first generic semaglutide for weight loss (Health Canada). First generic semaglutide authorized for chronic weight management.
  2. Diabetes Canada, Pharmacologic Glycemic Management guidelines (Diabetes Canada). How GLP-1 medicines fit into Canadian diabetes care.

Not a pharmacy

CompareTreatments Canada is not a pharmacy and not a medical provider. We do not sell, supply, or dispense medication, and we do not offer medical advice, diagnosis, or treatment. Any medication is provided by a licensed Canadian provider or pharmacy.

Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.

Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.